Metalabs to Absorb Subsidiary MetaS&C... Strengthening Competitiveness in Healthcare IT
On August 4, Metalabs (090370) announced that it will merge its subsidiary, MetaS&C, through absorption, in order to improve management efficiency and strengthen competitiveness in the healthcare IT business.
The purpose of this merger is to enhance operational efficiency by integrating its distributed organizations and work, and to internalize MetaS&C's specialized customer relationship management (CRM) solution for aesthetic medicine, as well as its medical consulting capabilities, as core businesses.
Established in 2014, MetaS&C has provided CRM solutions and management support services to aesthetic medical institutions such as plastic surgery clinics, dermatology clinics, and hair transplantation hospitals. Its proprietary CRM integrates and manages all aspects of customer management, including consultations, reservations, advertisement inflow sources, counseling performance, and telemarketing (TM), and features systematic marketing performance analysis.
Following the merger, Metalabs plans to efficiently reallocate human resources and management assets, and to streamline its decision-making structure to improve operational efficiency and profitability. In addition, leveraging its CRM development and operation capabilities, the company intends to expand collaboration between its medical network and affiliates, as well as further strengthen its digital healthcare business utilizing artificial intelligence (AI) and medical data.
A Metalabs official stated, "Through this merger, we have internalized our specialized CRM and medical consulting capabilities for aesthetic medicine as core businesses," adding, "We will not only optimize our organizational and cost structures, but also further reinforce the growth foundation for our healthcare IT business."
Last year, Metalabs posted consolidated revenue of 81.4 billion won, representing 112% year-on-year growth. Based on business structure optimization and cost control, the company achieved consolidated revenue of 30.4 billion won and operating profit of 500 million won in the first quarter of this year, successfully turning a profit.
The business expansion of its subsidiary MetaCare (118000) is also raising growth expectations. In June, MetaCare became the largest shareholder of TechLabs by acquiring 47.51% of its shares. With TechLabs, which recorded 92.3 billion won in revenue and 7.4 billion won in operating profit last year, now being consolidated as a subsidiary, Metalabs expects to further reinforce both its top-line growth and profitability.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
This absorption-type merger is seen as a strategic move to internalize aesthetic medical CRM capabilities, enhance organizational efficiency, and at the same time strengthen AI-based digital healthcare business and group-level growth drivers.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.